Carregant...
Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives
Luminal breast cancer, as defined by oestrogen and/or progesterone expression by immunohistochemistry, accounts for up to 75% of all breast cancers. In this population, endocrine therapy is likely to account for most of the gains obtained with the administration of adjuvant systemic treatment. The r...
Guardat en:
| Publicat a: | Ecancermedicalscience |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cancer Intelligence
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4720494/ https://ncbi.nlm.nih.gov/pubmed/26823678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.609 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|